Incyte (INCY) Reports Q1 EPS of 12c, Updates FY Guidance
Incyte (NASDAQ: INCY) reported Q1 EPS of $0.12, $0.08 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $263 million versus the consensus estimate of $263.97 million.
2016 Financial Guidance
The Company has updated its full year 2016 financial guidance, as detailed below.
Incyte | ARIAD EU | Combined | ||||
Jakafi net product revenues | $815-$830 million(previously $800-$815 million) | - | $815-$830 million | |||
Iclusig net product revenues | - | $25-$30 million | $25-$30 million | |||
Research and development expenses | $620-$640 million(no change) | $15-$20 million | $635-$660 million | |||
Selling, general and administrative expenses | $255-$275 million(previously $255-$270 million) | $30-$35 million | $285-$310 million |
For earnings history and earnings-related data on Incyte (INCY) click here.